NICOLE XANDERS-DANLER: Open Payments
NPI 1083374292 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 20 payments from 8 companies in 2025. Trend: 2023 $1,464 · 2024 $423 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $176 |
| Corium, LLC | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
Products named: CAPLYTA, Azstarys, REXULTI, COBENFY, FANAPT, Qelbree, INGREZZA, ARISTADA.
Industry payments across KS — which companies pay providers there.
